165 related articles for article (PubMed ID: 18758476)
41. [Regulation of cell-cycle exit and G0-phase maintenance during differentiation by Fbxw7].
Onoyama I; Nakayama K
Tanpakushitsu Kakusan Koso; 2008 Aug; 53(10):1217-24. PubMed ID: 18681173
[No Abstract] [Full Text] [Related]
42. Modulating the strength and threshold of NOTCH oncogenic signals by mir-181a-1/b-1.
Fragoso R; Mao T; Wang S; Schaffert S; Gong X; Yue S; Luong R; Min H; Yashiro-Ohtani Y; Davis M; Pear W; Chen CZ
PLoS Genet; 2012; 8(8):e1002855. PubMed ID: 22916024
[TBL] [Abstract][Full Text] [Related]
43. NOTCH receptors in gastric and other gastrointestinal cancers: oncogenes or tumor suppressors?
Huang T; Zhou Y; Cheng AS; Yu J; To KF; Kang W
Mol Cancer; 2016 Dec; 15(1):80. PubMed ID: 27938406
[TBL] [Abstract][Full Text] [Related]
44. IKAROS is required for the measured response of NOTCH target genes upon external NOTCH signaling.
Lemarié M; Bottardi S; Mavoungou L; Pak H; Milot E
PLoS Genet; 2021 Mar; 17(3):e1009478. PubMed ID: 33770102
[TBL] [Abstract][Full Text] [Related]
45. Tumor suppression in T cell leukemia--the role of Ikaros.
Dovat S; Payne KJ
Leuk Res; 2010 Apr; 34(4):416-7. PubMed ID: 19892402
[No Abstract] [Full Text] [Related]
46. Notch is oncogenic dominant in T-cell acute lymphoblastic leukemia.
Demarest RM; Dahmane N; Capobianco AJ
Blood; 2011 Mar; 117(10):2901-9. PubMed ID: 21217079
[TBL] [Abstract][Full Text] [Related]
47. Notch as a tumour suppressor.
Nowell CS; Radtke F
Nat Rev Cancer; 2017 Mar; 17(3):145-159. PubMed ID: 28154375
[TBL] [Abstract][Full Text] [Related]
48. Role of Notch Receptors in Hematologic Malignancies.
Gragnani L; Lorini S; Marri S; Zignego AL
Cells; 2020 Dec; 10(1):. PubMed ID: 33374160
[TBL] [Abstract][Full Text] [Related]
49. Emerging roles of deubiquitinases in cancer-associated pathways.
Sacco JJ; Coulson JM; Clague MJ; Urbé S
IUBMB Life; 2010 Feb; 62(2):140-57. PubMed ID: 20073038
[TBL] [Abstract][Full Text] [Related]
50. Roles of Notch Signaling in the Tumor Microenvironment.
D'Assoro AB; Leon-Ferre R; Braune EB; Lendahl U
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682918
[TBL] [Abstract][Full Text] [Related]
51. Introduction to Molecular Mechanisms in Notch Signal Transduction and Disease Pathogenesis.
Giaimo BD; Borggrefe T
Adv Exp Med Biol; 2018; 1066():3-30. PubMed ID: 30030819
[TBL] [Abstract][Full Text] [Related]
52. Itchy mice: the identification of a new pathway for the development of autoimmunity.
Matesic LE; Copeland NG; Jenkins NA
Curr Top Microbiol Immunol; 2008; 321():185-200. PubMed ID: 18727493
[TBL] [Abstract][Full Text] [Related]
53. Notch and cancer: a double-edged sword.
Koch U; Radtke F
Cell Mol Life Sci; 2007 Nov; 64(21):2746-62. PubMed ID: 17687513
[TBL] [Abstract][Full Text] [Related]
54. Cutaneous Notch signaling in health and disease.
Nowell C; Radtke F
Cold Spring Harb Perspect Med; 2013 Dec; 3(12):a017772. PubMed ID: 24296353
[TBL] [Abstract][Full Text] [Related]
55. Crosstalk of Notch with p53 and p63 in cancer growth control.
Dotto GP
Nat Rev Cancer; 2009 Aug; 9(8):587-95. PubMed ID: 19609265
[TBL] [Abstract][Full Text] [Related]
56. Notch signalling in solid tumours: a little bit of everything but not all the time.
Ranganathan P; Weaver KL; Capobianco AJ
Nat Rev Cancer; 2011 May; 11(5):338-51. PubMed ID: 21508972
[TBL] [Abstract][Full Text] [Related]
57. Impact of Notch disruption on myeloid development.
Francis OL; Chaudhry KK; Lamprecht T; Klco JM
Blood Cancer J; 2017 Aug; 7(8):e598. PubMed ID: 28841212
[No Abstract] [Full Text] [Related]
58. Ikaros, Notch, and GATA1 cross paths during megakaryopoiesis.
Maillard I
Blood; 2013 Mar; 121(13):2376-7. PubMed ID: 23538229
[No Abstract] [Full Text] [Related]
59. Compacting the heart with Notch.
Misra C; Garg V
Nat Med; 2013 Feb; 19(2):133-4. PubMed ID: 23389606
[No Abstract] [Full Text] [Related]
60. Tissue-Predisposition to Cancer Driver Mutations.
Peters L; Venkatachalam A; Ben-Neriah Y
Cells; 2024 Jan; 13(2):. PubMed ID: 38247798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
